Effectiveness of treatments for severe sepsis: Data from the bundle implementation programs

Minerva Anestesiologica

Volumn 77, Issue 3, 2011, Pages 360-365

  Ferrer, R ^a   Artigas, A ^a  

^a HOSPITAL DE SABADELL   (Spain)

Author keywords

Antibiotics; Bundle care; Sepsis

Indexed keywords

ACTIVATED PROTEIN C; ANTIBIOTIC AGENT; CORTICOSTEROID DERIVATIVE; DROTRECOGIN; HYPERTENSIVE AGENT;

ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BLOOD GLUCOSE MONITORING; CENTRAL VENOUS PRESSURE; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; HEALTH PROGRAM; HEMODYNAMIC MONITORING; HUMAN; LOW DRUG DOSE; MEAN ARTERIAL PRESSURE; MORTALITY; MULTIPLE ORGAN FAILURE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; OXYGEN SATURATION; PATIENT CARE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PROPENSITY SCORE; RISK BENEFIT ANALYSIS; RISK REDUCTION; SEPSIS; SEPTIC SHOCK; STRESS ULCER; TREATMENT OUTCOME; TREATMENT PLANNING;

ADRENAL CORTEX HORMONES; BLOOD GLUCOSE; COMBINED MODALITY THERAPY; EVIDENCE-BASED MEDICINE; FIBRINOLYTIC AGENTS; HOSPITAL MORTALITY; HUMANS; META-ANALYSIS AS TOPIC; PROTEIN C; RECOMBINANT PROTEINS; RESPIRATORY FUNCTION TESTS; SEPSIS; SHOCK, SEPTIC; SURVIVAL; TREATMENT OUTCOME;

EID: 79953725981     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-10.
2. Brun-Buisson C, Doyon F, Carlet J, Dellamonica P, Gouin F, Lepoutre A et al. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. JAMA 1995;274:968-74.
3. Guidet B, Aegerter P, Gauzit R, Meshaka P, Dreyfuss D. Incidence and impact of organ dysfunctions associated with sepsis. Chest 2005;127:942-51.
4. Esteban A, Frutos-Vivar F, Ferguson ND, Penuelas O, Lorente JA, Gordo F et al. Sepsis incidence and outcome: contrasting the intensive care unit with the hospital ward. Crit Care Med 2007;35:1284-9.
5. Alberti C, Brun-Buisson C, Burchardi H, Martin C, Goodman S, Artigas A et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 2002;28:108-21.
6. Rubulotta FM, Ramsay G, Parker MM, Dellinger RP, Levy MM, Poeze M. An international survey: Public awareness and perception of sepsis. Crit Care Med 2009;37:167-70.
7. Abraham E, Singer M. Mechanisms of sepsis-induced organ dysfunction. Crit Care Med 2007;35:2408-16.
8. Wheeler AP. Recent developments in the diagnosis and management of severe sepsis. Chest 2007;132:1967-76.
9. Garnacho-Montero J, Garcia-Garmendia JL, Barrero-Almodovar A, Jimenez-Jimenez FJ, Perez-Paredes C, Ortiz-Leyba C. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med 2003;31:2742-51.
10. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006;34:1589-96.
11. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368-77.
12. Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002;288:862-71.
13. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344:699-709.
14. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001;345:1359-67.
15. [No authors listed]. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000;342:1301-8.
16. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004;30:536-55.
17. Gao F, Melody T, Daniels DF, Giles S, Fox S. The impact of compliance with 6-hour and 24-hour sepsis bundles on hospital mortality in patients with severe sepsis: a prospective observational study. Crit Care 2005;9:R764-R770.
18. Micek ST, Roubinian N, Heuring T, Bode M, Williams J, Harrison C et al. Before-after study of a standardized hospital order set for the management of septic shock. Crit Care Med 2006;34:2707-13.
19. Kortgen A, Niederprum P, Bauer M. Implementation of an evidence-based "standard operating procedure" and outcome in septic shock. Crit Care Med 2006;34:943-9.
20. Shapiro NI, Howell MD, Talmor D, Lahey D, Ngo L, Buras J et al. Implementation and outcomes of the Multiple Urgent Sepsis Therapies (MUST) protocol. Crit Care Med 2006;34:1025-32.
21. Nguyen HB, Corbett SW, Steele R, Banta J, Clark RT, Hayes SR et al. Implementation of a bundle of quality indicators for the early management of severe sepsis and septicshock is associated with decreased mortality. Crit Care Med 2007;35:1105-12.
22. Jones AE, Focht A, Horton JM, Kline JA. Prospective external validation of the clinical effectiveness of an emergency department-based early goal-directed therapy protocol for severe sepsis and septic shock. Chest 2007;132:425-32.
23. Barochia AV, Cui X, Vitberg D, Suffredini AF, O'grady NP, Banks SM et al. Bundled care for septic shock: an analysis of clinical trials. Crit Care Med 2010;38:668-78.
24. Schuerholz T, Marx G. Management of sepsis. Minerva Anestesiol 2008;74:181-95.
25. Ferrer R, Artigas A, Levy MM, Blanco J, Gonzalez-Diaz G, Garnacho-Montero J et al. Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA 2008;299:2294-303.
26. Levy MM, Dellinger RP, Townsend SR, Linde-Zwirble WT, Marshall JC, Bion J et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med 2010;36:222-31.
27. Natanson C, Danner RL, Reilly JM, Doerfler ML, Hoffman WD, Akin GL et al. Antibiotics versus cardiovascular support in a canine model of human septic shock. Am J Physiol 1990;259(5 Pt 2):H1440-H7.
28. Delaney A, Angus DC, Bellomo R, Cameron P, Cooper DJ, Finfer S et al. Bench-to-bedside review: the evaluation of complex interventions in critical care. Crit Care 2008;12:210.
29. Finfer S, Ranieri VM, Thompson BT, Barie PS, Dhainaut JF, Douglas IS et al. Design, conduct, analysis and reporting of a multi-national placebo-controlled trial of activated protein C for persistent septic shock. Intensive Care Med 2008;34:1935-47.
30. Ferrer R, Artigas A, Suarez D, Palencia E, Levy MM, Arenzana A et al. Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study. Am J Respir Crit Care Med 2009;180:861-6.